Brain and Psychology Study of Hard-to-Treat Migraines
Part of Brain & nervous system, Pain clinical trials.
This research study compares brain structure and psychological traits in people with chronic migraines that don't respond well to standard treatments versus healthy volunteers without migraines. Understanding these differences may help doctors develop better treatment options for difficult-to-treat migraines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have chronic migraines (at least 8 migraine days per month) that significantly limit your daily activities
- You have tried at least three different migraine preventive medications for at least 6 weeks each, without adequate relief or you couldn't tolerate them
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have a history of alcohol or drug abuse
- You do not have certain other brain, heart, or psychiatric conditions (liver or kidney disease, psychosis, major depression, or bipolar disorder)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a gentle brain-stimulation technique called tDCS (which uses a small electrical current on the scalp) can reduce how often you get migraines. If you're already on a preventive medication, this might add extra relief.
This study looks at thinking abilities and psychological factors in people with migraines. It aims to understand how migraine affects memory, attention, and emotions.
This study looks at why headaches can become long-lasting (“chronified”) by combining answers from online questionnaires, brain imaging, and blood protein tests. Your participation may help researchers find biological clues that could improve how headache problems are understood and treated.
This study looks at how preventive treatments for severe migraines, like botulinum toxin injections or anti-CGRP antibody infusions, may affect thinking and quality of life. If you have frequent migraines that don't respond to other treatments, you might be able to join.
This study looks at how psilocybin affects the brain in people with migraines and in healthy volunteers. The goal is to understand why it may help with headache disorders.
This study looks at how migraine may start or affect children by comparing young people who either have migraine symptoms or are at higher risk. It may help researchers understand migraine patterns and who could benefit from early prevention.
Hear when a new Chronic Migraine Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.